000908 *ST景峰医药
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)51.484-500.552-54.114-43.523-98.320
总资产报酬率 ROA (%)-4.684-18.754-7.585-6.887-27.773
投入资产回报率 ROIC (%)-7.646-30.059-11.048-9.446-36.179

边际利润分析
销售毛利率 (%)59.92671.75876.28862.08763.785
营业利润率 (%)-9.852-26.322-8.127-15.401-115.668
息税前利润/营业总收入 (%)-7.935-23.423-4.084-7.205-106.815
净利润/营业总收入 (%)-16.810-34.626-11.331-23.506-119.279

收益指标分析
经营活动净收益/利润总额(%)83.00369.97558.938249.94662.127
价值变动净收益/利润总额(%)0.874-14.854-16.140-177.348-21.375
营业外收支净额/利润总额(%)41.30511.15620.22013.5302.713

偿债能力分析
流动比率 (X)0.1950.2050.5270.4980.550
速动比率 (X)0.1440.1430.4160.3840.425
资产负债率 (%)121.858116.47086.16682.55777.107
带息债务/全部投入资本 (%)96.84292.29570.98770.08768.523
股东权益/带息债务 (%)-19.887-11.59825.43231.48431.313
股东权益/负债合计 (%)-9.551-5.70513.12119.67820.160
利息保障倍数 (X)-0.897-3.775-0.669-0.679-8.844

营运能力分析
应收账款周转天数 (天)58.61067.16879.197143.424233.146
存货周转天数 (天)134.851179.444249.019226.966316.292